Tumor microenvironment signaling and therapeutics in cancer progression

A Goenka, F Khan, B Verma, P Sinha… - Cancer …, 2023 - Wiley Online Library
Tumor development and metastasis are facilitated by the complex interactions between
cancer cells and their microenvironment, which comprises stromal cells and extracellular …

[HTML][HTML] Artificial intelligence in dermatology image analysis: current developments and future trends

Z Li, KC Koban, TL Schenck, RE Giunta, Q Li… - Journal of clinical …, 2022 - mdpi.com
Background: Thanks to the rapid development of computer-based systems and deep-
learning-based algorithms, artificial intelligence (AI) has long been integrated into the …

Nanoprobe-based molecular imaging for tumor stratification

X Ma, M Mao, J He, C Liang, HY **e - Chemical Society Reviews, 2023 - pubs.rsc.org
The responses of patients to tumor therapies vary due to tumor heterogeneity. Tumor
stratification has been attracting increasing attention for accurately distinguishing between …

The complexity of immune evasion mechanisms throughout the metastatic cascade

NM Haynes, TB Chadwick, BS Parker - Nature Immunology, 2024 - nature.com
Metastasis, the spread of cancer from a primary site to distant organs, is an important
challenge in oncology. This Review explores the complexities of immune escape …

Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application

Y Zhang, M Xu, Y Ren, Y Ba, S Liu, A Zuo, H Xu… - Molecular Cancer, 2024 - Springer
Tertiary lymphoid structures (TLS) are clusters of immune cells that resemble and function
similarly to secondary lymphoid organs (SLOs). While TLS is generally associated with an …

Advancing nanotechnology for neoantigen-based cancer theranostics

J Zou, Y Zhang, Y Pan, Z Mao, X Chen - Chemical Society Reviews, 2024 - pubs.rsc.org
Neoantigens play a pivotal role in the field of tumour therapy, encompassing the stimulation
of anti-tumour immune response and the enhancement of tumour targeting capability …

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

SC Selvakumar, KA Preethi, K Ross, D Tusubira… - Molecular Cancer, 2022 - Springer
Background Cancer is caused by a combination of genetic and epigenetic abnormalities.
Current cancer therapies are limited due to the complexity of their mechanism, underlining …

Leveraging physiology and artificial intelligence to deliver advancements in health care

A Zhang, Z Wu, E Wu, M Wu, MP Snyder… - Physiological …, 2023 - journals.physiology.org
Artificial intelligence in health care has experienced remarkable innovation and progress in
the last decade. Significant advancements can be attributed to the utilization of artificial …

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy

L Dercle, J McGale, S Sun, A Marabelle… - Journal for …, 2022 - pmc.ncbi.nlm.nih.gov
Immunotherapy offers the potential for durable clinical benefit but calls into question the
association between tumor size and outcome that currently forms the basis for imaging …

Malignant melanoma: An overview, new perspectives, and vitamin D signaling

RM Slominski, TK Kim, Z Janjetovic, AA Brożyna… - Cancers, 2024 - mdpi.com
Simple Summary Despite recent advances in diagnosis and therapy, malignant melanoma
poses a significant problem both to clinicians and cancer researchers due to its resistance to …